Firehawk Rapamycin Target Eluting Coronary Stent North American Trial
Clinical trial NCT04562532 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04562532
- Sponsor
- Shanghai MicroPort Medical (Group) Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-17
- Primary completion
- 2023-12-10
- Enrollment
- 1720
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.